Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: Safety, efficacy, and radiographic outcomes
Genovese MC et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key121
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.